Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients

Summary

Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active.

Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence.

Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care.

Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity.

However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity.

This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients:

* 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers)
* 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up
* 3-Support by health professionals (attending physician) through the prescription of physical activity.

The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.

Conditions

• Prostate Cancer

Interventions

BEHAVIORAL

Acti-Pair program

Motivational support by the peer (a patient with the same pathology who meets the WHO recommendations for physical activity), who will provide motivational follow-up * The implementation of a personalized and realistic physical activity project for the patient via the physical activity support systems (sport health centers) * Support from health professionals (GP) via the prescription of physical activity and from adapted physical activity (APA) professionals

Sponsors & Collaborators

• Sport Health Center of Auvergne-Rhône Alpes

  collaborator UNKNOWN

• INSERM, SAINBIOSE U1059

  collaborator UNKNOWN

• Institut National de la Santé Et de la Recherche Médicale, France

  collaborator OTHER_GOV

• INSERM ECEVE 1123

  collaborator UNKNOWN

• Ministry of Health, France

  collaborator OTHER_GOV

• Centre Hospitalier Universitaire de Saint Etienne

  lead OTHER

Principal Investigators

• David HUPIN, MD PhD · CHU de Saint-Etienne

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

MALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-04-25

Primary Completion

2027-09-30

Completion

2028-09-30

Countries

• France

Study Locations